Lung Cancer Screening Market Size Report & Overview 2022-2030
[Research Report] The lung cancer screening market size is projected to reach US$ 4,363.95 million by 2030 from US$ 2,326.5 million in 2022. It is expected to register a CAGR of 8.2% from 2022 to 2030.
Analyst Perspective:
The rising incidence of lung cancer and increasing government support drive the lung cancer screening market expansion. With the high pervasiveness of lung cancer, the awareness of the disease and the associated treatment are also rising. Additionally, government initiatives provide better and more affordable screening and favorable reimbursement policies, which are expected to boost the lung cancer screening market growth. The lung cancer screening market key players are focusing on strategic initiatives by collaborations to expand their geographic reach and enhance capacities to cater to a large customer base. For instance, in November 2021, GE Healthcare and Optellum collaborated to advance precision diagnosis and treatment of lung cancer. Together, the companies seek to address one of the largest challenges in diagnosing lung cancer, helping providers determine the malignancy of a lung nodule: a suspicious lesion that may be benign or cancerous.
Lung Cancer Screening Market - Market Overview:
Lung cancer screening is a process used to detect lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening is recommended for older adults who are long time smokers and who do not have any signs or symptoms of lung cancer. Doctors use a LDCT scan of the lungs to look for lung cancer. If lung cancer is detected early, it is more likely to be cured with treatment.
The lung cancer screening market is segmented into technology, cancer type, age group, and end user. The report offers insights and in-depth analysis of the global lung cancer screening emphasizing on parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Lung Cancer Screening Market: Strategic Insights
Market Size Value in US$ 2,326.5 million in 2022 Market Size Value by US$ 4,363.95 million by 2030 Growth rate CAGR of 8.2% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Lung Cancer Screening Market: Strategic Insights
| Market Size Value in | US$ 2,326.5 million in 2022 |
| Market Size Value by | US$ 4,363.95 million by 2030 |
| Growth rate | CAGR of 8.2% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Driver:
Increasing Incidence of Lung Cancer Drives Lung Cancer Screening Market
Lung cancer is among the main causes of mortality across the world. Lung cancer screening is a critical component of cancer prevention approaches. The prognosis for lung cancer patients is better when the disease is diagnosed early, so people at high risk of lung cancer are encouraged to undergo routine testing to detect the formation of cancerous growth in their lungs. According to estimates by the American Cancer Society for lung cancer in the US for 2023, about 238,340 new lung cancer cases were registered; of these, 120,790 in women and 117,550 in men were reported. Also, according to the National Center for Biotechnology Information (NCBI), each year, ~41,000 new diagnoses of lung cancers and 34,000 deaths are recorded in Italy.
As per the Cancer Australia 2023 report, ~14,529 new lung cancer cases were diagnosed in 2022; among these, 7,707 were males and 6,822 were females. Nearly 9% of registered new cancer cases were diagnosed in 2022, with an estimated 8,664 total deaths due to lung cancer.
Thus, the rising incidence of lung cancer worldwide is contributing to the initiation of lung cancer screening programs, which is, in turn, driving the lung cancer screening market growth.
Lung Cancer Screening Market - Segmental Analysis:
Based on cancer type, the lung cancer screening market is bifurcated into non-small cell lung cancer (NSCLC) and small cell lung cancer. The NSCLC segment accounted for a larger market share in 2022 and is expected to grow at a CAGR of 8.0% during the forecast period. The market position of this segment is due to the rising cases of NSCLC across the world. NSCLC develops more slowly than small cell lung cancer. It usually spreads to other parts of the patient's body by the time it is diagnosed. Therefore, early diagnosis and treatment are crucial. According to National Foundation for Cancer Research, NSCLC accounts for nearly 9 out of every 10 diagnoses. As per the same source, large-cell undifferentiated carcinoma lung cancer accounts for ~10–15% of all NSCLC diagnoses.
Lung Cancer Screening Market - Regional Analysis:
The increasing prevalence of lung cancer has made its screening extremely important for early detection. Lung cancer screening is suggested for older adults who are long-time smokers and do not have any symptoms related to lung cancer. Physicians use a low-dose computerized tomography (LDCT) scan or X-ray for screening.
According to an article titled “Lung Cancer in Germany,” published in the Journal of Thoracic Oncology, in June 2022, cancer is among the second most frequent cause of death in Germany, accounting for 25% of all deaths. In men, lung cancer ranks second after cardiovascular disease, accounting for 6.5% of all-cause mortality. With an age-standardized incidence rate of 52.1 and 32.7 and (per 100,000) in men and women, respectively, lung cancer ranks second in men and third in women (accounting for 13.3% and 9.4% of all newly diagnosed cancers, respectively). The average age of cancer diagnosis is 70 years (men) and 69 years (women); 52% of all patients present with stage IV. The incidence rates in women and men have converged since the 1990s because of long-term changes in smoking habits. Currently, every fourth man (27.0%) and every fifth woman (20.8%) in Germany smokes regularly.
The German National Cancer Plan designates organ cancer centers (lung cancer centers), oncology centers, and comprehensive cancer centers to offer general oncologic care in Germany. As of 2020, 64 lung cancer centers at 79 institutions were certified nationwide. Further, the implementation of lung cancer screening in the German healthcare system is expected in the upcoming years. For example, the HANSE, a lung check study, is primarily intended as a pilot program to provide evidence that a holistic and effective lung cancer screening program can be implemented and integrated into the current infrastructure of certified lung cancer centers in Germany. The HANSE investigates the feasibility of controlled lung cancer screening, screening for relevant cardiac and pulmonary comorbidities, and assessing potential predictive biomarkers in 5,000 high-risk candidates in the Northern German region. The screening is facilitated by a mobile CT truck rotating among three approved lung cancer centers. In addition, Germany is participating with two sites in the European “4 in the Lung Run–Study,” a prospective trial that is investigating several innovative modifications of screening, including personalized recruitment approaches, individualized screening intervals, improved radiological criteria, and others.
Thus, with rising lung cancer incidences in Germany and the implementation of lung cancer screening in the German healthcare system, the market for lung cancer screening is expected to grow.
Lung Cancer Screening Market - Key Player Analysis:
The lung cancer screening market analysis involved the study of players such as Intelerad Medical Systems Incorporated; Nuance Communications Inc; GE HealthCare Technologies Inc; Medtronic Plc; Canon Medical Systems Corp; Koninklijke Philips NV; Siemens AG; Aetna Inc; bioAffinity Technologies, Inc.; and LungLife AI, Inc. Among the players in the lung cancer screening market, Siemens AG and Medtronic Plc are the top two players owing to the diversified product portfolio offered.
Lung Cancer Screening Market Report Scope
Lung Cancer Screening Market - Recent Developments:
Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the lung cancer screening market. A few recent key market developments are listed below:
- In June 2022, Royal Philips teamed up with Biodesix, Inc. to incorporate the results of Biodesix’s Nodify Lung blood-based lung nodule risk assessment testing into Philips Lung Cancer Orchestrator lung cancer patient management system.
- In August 2022, Intelerad Medical Systems acquired PenRad Technologies, Inc., a software provider for enhancing breast imaging and lung screening productivity. The acquisition has expanded Intelerad’s product offerings for mammography and lung analytics, optimizing workflow for radiologists and boosting patient health outcomes.
- In May 2021, Genetron Holdings Limited partnered with Siemens Healthineers at the China Medical Equipment Fair. This partnership promoted the large-scale application of Genetron’s S5 platform and lung cancer 8-gene IVD assay in Chinese hospitals and provided NSCLC patients with efficient and accurate personalized diagnosis and treatment guidance.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Cancer Type, Technology, Age Group, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors such as rising lung cancer incidence and increasing government support drive the market growth. However, high cost of lung screening tests hinders the market growth.
Structured lung cancer screening program is likely to fuel the market growth in the coming years.
Small cell lung cancer segment is growing in the lung cancer screening market.
Lung cancer screening is a process used to detect lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening is recommended for older adults who are long time smokers and who don't have any signs or symptoms of lung cancer. Doctors use a low-dose computerized tomography (LDCT) scan of the lungs to look for lung cancer. If lung cancer is detected early, it's more likely to be cured with treatment.
The lung cancer screening market majorly consists of the players such as Intelerad Medical Systems Incorporated, Nuance Communications Inc, GE HealthCare Technologies Inc, Medtronic Plc, Canon Medical Systems Corp, Koninklijke Philips NV, Siemens AG, Aetna Inc, bioAffinity Technologies, Inc., and LungLife AI, Inc., among others.
Mobile lung cancer screening truck in lung cancer screening market is likely to trend the market growth in the coming years.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Lung Cancer Screening Market – by Technology
1.3.2 Global Lung Cancer Screening Market – by Cancer Type
1.3.3 Global Lung Cancer Screening Market – by Age Group
1.3.4 Global Lung Cancer Screening Market – by End User
1.3.5 Global Lung Cancer Screening Market – by Geography
2. Lung Cancer Screening Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Lung Cancer Screening Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Lung Cancer Screening Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Lung Cancer Incidences
5.1.2 Increasing Government Support
5.2 Market Restraints
5.2.1 High Cost of Lung Cancer Screening Tests
5.3 Market Opportunities
5.3.1 Structured Lung Cancer Screening Program
5.4 Future Trends
5.4.1 Mobile Lung Cancer Screening Truck
5.5 Impact Analysis
6. Lung Cancer Screening Market – Global Analysis
6.1 Global Lung Cancer Screening Market Revenue Forecast and Analysis
6.2 Global Lung Cancer Screening Market, by Geography – Forecast and Analysis
7. Global Lung Cancer Screening Market – Revenue and Forecast to 2028 – By Cancer Type
7.1 Overview
7.2 Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
7.3 Non–Small Cell Lung Cancer (NSCLC)
7.3.1 Overview
7.3.2 Non–Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Mn)
7.4 Small Cell Lung Cancer
7.4.1 Overview
7.4.2 Small Cell Lung Cancer: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
8. Lung Cancer Screening Market Analysis – by Technology
8.1 Overview
8.2 Low-Dose Computed Tomography (LDCT)
8.2.1 Overview
8.2.2 Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
8.3 Chest X-ray
8.3.1 Overview
8.3.2 Chest X-ray: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
8.4 Liquid Biopsy
8.4.1 Overview
8.4.2 Liquid Biopsy: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
9. Lung Cancer Screening Market Analysis – by Age Group
9.1 Overview
9.2 & Older
9.2.1 Overview
9.2.2 & Older: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Below 50
9.3.1 Overview
9.3.2 Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
10. Lung Cancer Screening Market Analysis – by End User
10.1 Overview
10.2 Hospitals
10.2.1 Overview
10.2.2 Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
11. Lung Cancer Screening Market – Revenue and Forecast to 2028 – Geographic Analysis
11.1 North America: Lung Cancer Screening Market
11.1.1 Overview
11.1.2 North America: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.4 North America: Lung Cancer Screening Market, by Technology – 2020-2030 (US$ Million)
11.1.5 North America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.6 North America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.6.1 US: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.1.1 Overview
11.1.6.1.2 US: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.1.3 US: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.6.1.4 US: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.1.6.1.5 US: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.6.1.6 US: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.6.2 Canada: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.2.1 Overview
11.1.6.2.2 Canada: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.2.3 Canada: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.6.2.4 Canada: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.1.6.2.5 Canada: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.6.2.6 Canada: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.6.3 Mexico: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.3.1 Overview
11.1.6.3.2 Mexico: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.3.3 Mexico: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.6.3.4 Mexico: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.1.6.3.5 Mexico: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.6.3.6 Mexico: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.2 Europe: Lung Cancer Screening Market
11.2.1 Overview
11.2.2 Europe: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3 Europe: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.2.4 Europe: Lung Cancer Screening Market, by Technology – 2020-2030 (US$ Million)
11.2.5 Europe: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.2.6 Europe: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.2.6.1 Germany: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.6.1.1 Overview
11.2.6.1.2 Germany: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.6.1.3 Germany: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.2.6.1.4 Germany: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.2.6.1.5 Germany: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.2.6.1.6 Germany: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.2.6.2 UK: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.6.2.1 Overview
11.2.6.2.2 UK: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.6.2.3 UK: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.2.6.2.4 UK: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.2.6.2.5 UK: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.2.6.2.6 UK: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.2.6.3 France: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.6.3.1 Overview
11.2.6.3.2 France: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.6.3.3 France: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.2.6.3.4 France: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.2.6.3.5 France: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.2.6.3.6 France: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.2.6.4 Italy: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.6.4.1 Overview
11.2.6.4.2 Italy: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.6.4.3 Italy: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.2.6.4.4 Italy: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.2.6.4.5 Italy: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.2.6.4.6 Italy: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.2.6.5 Spain: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.6.5.1 Overview
11.2.6.5.2 Spain: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.6.5.3 Spain: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.2.6.5.4 Spain: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.2.6.5.5 Spain: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.2.6.5.6 Spain: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.2.6.6 Rest of Europe: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.6.6.1 Overview
11.2.6.6.2 Rest of Europe: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.2.6.6.3 Rest of Europe: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.2.6.6.4 Rest of Europe: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.2.6.6.5 Rest of Europe: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.2.6.6.6 Rest of Europe: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.3 Asia-Pacific: Lung Cancer Screening Market
11.3.1 Overview
11.3.2 Asia Pacific: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3 Asia Pacific: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.3.4 Asia Pacific: Lung Cancer Screening Market, by Technology – 2020-2030 (US$ Million)
11.3.5 Asia Pacific: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.3.6 Asia Pacific: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.3.6.1 China: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.6.1.1 Overview
11.3.6.1.2 China: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.6.1.3 China: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.3.6.1.4 China: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.3.6.1.5 China: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.3.6.1.6 China: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.3.6.2 Japan: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.6.2.1 Overview
11.3.6.2.2 Japan: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.6.2.3 Japan: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.3.6.2.4 Japan: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.3.6.2.5 Japan: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.3.6.2.6 Japan: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.3.6.3 India: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.6.3.1 Overview
11.3.6.3.2 India: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.6.3.3 India: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.3.6.3.4 India: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.3.6.3.5 India: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.3.6.3.6 India: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.3.6.4 Australia: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.6.4.1 Overview
11.3.6.4.2 Australia: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.6.4.3 Australia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.3.6.4.4 Australia: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.3.6.4.5 Australia: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.3.6.4.6 Australia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.3.6.5 South Korea: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.6.5.1 Overview
11.3.6.5.2 South Korea: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.6.5.3 South Korea: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.3.6.5.4 South Korea: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.3.6.5.5 South Korea: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.3.6.5.6 South Korea: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.3.6.6 Rest of Asia Pacific: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.6.6.1 Overview
11.3.6.6.2 Rest of Asia Pacific: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.3.6.6.3 Rest of Asia Pacific: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.3.6.6.4 Rest of Asia Pacific: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.3.6.6.5 Rest of Asia Pacific: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.3.6.6.6 Rest of Asia Pacific: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.4 Middle East & Africa: Lung Cancer Screening Market
11.4.1 Overview
11.4.2 Middle East & Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3 Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.4.4 Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.4.5 Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.4.5.1.1 Middle East & Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.4.5.2 South Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.4.5.2.1 Overview
11.4.5.2.2 South Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.4.5.2.3 South Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.4.5.2.4 South Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.4.5.2.5 South Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.4.5.2.6 South Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.4.5.3 Saudi Arabia: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.4.5.3.1 Overview
11.4.5.3.2 Saudi Arabia: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.4.5.3.3 Saudi Arabia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.4.5.3.4 Saudi Arabia: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.4.5.3.5 Saudi Arabia Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.4.5.3.6 Saudi Arabia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.4.5.4 UAE: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.4.5.4.1 Overview
11.4.5.4.2 UAE: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.4.5.4.3 UAE: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.4.5.4.4 UAE: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.4.5.4.5 UAE Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.4.5.4.6 UAE: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.4.5.5 Rest of Middle East & Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.4.5.5.1 Overview
11.4.5.5.2 Rest of Middle East & Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.4.5.5.3 Rest of Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.4.5.5.4 Rest of Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.4.5.5.5 Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.4.5.5.6 Rest of Middle East & Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.5 South & Central America: Lung Cancer Screening Market
11.5.1 Overview
11.5.2 South & Central America: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3 South & Central America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.5.4 South & Central America: Lung Cancer Screening Market, by Technology – 2020-2030 (US$ Million)
11.5.5 South & Central America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.5.6 South & Central America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.5.6.1 Brazil: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.5.6.1.1 Overview
11.5.6.1.2 Brazil: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.5.6.1.3 Brazil: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.5.6.1.4 Brazil: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.5.6.1.5 Brazil: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.5.6.1.6 Brazil: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.5.6.2 Argentina: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.5.6.2.1 Overview
11.5.6.2.2 Argentina: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.5.6.2.3 Argentina: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.5.6.2.4 Argentina: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.5.6.2.5 Argentina: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.5.6.2.6 Argentina: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.5.6.3 Rest of South & Central America: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.5.6.3.1 Overview
11.5.6.3.2 Rest of South & Central America: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.5.6.3.3 Rest of South & Central America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.5.6.3.4 Rest of South & Central America: Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
11.5.6.3.5 Rest of South & Central America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.5.6.3.6 Rest of South & Central America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
12. Pre and Post COVID-19 Impact on Lung Cancer Screening Market
12.1 Impact Analysis of COVID-19 Pandemic on Lung Cancer Screening Market
13. Lung Cancer Screening Market–Industry Landscape
13.1 Recent Growth Strategies
13.1.1 Overview
14. Company Profiles
14.1 Intelerad Medical Systems
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Nuance Communications Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GE HealthCare
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Medtronic
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Canon Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Koninklijke Philips NV
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Siemens AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 CVS Health
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 bioAffinity Technologies, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 LungLife AI, Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 2. North America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 5. US Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 6. US Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 7. US Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 8. US Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 10. Canada Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 14. Mexico Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 17. Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 19. Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 20. Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 21. Germany Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 22. Germany Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 23. Germany Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 24. Germany Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 25. UK Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 26. UK Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 27. UK Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 28. UK Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 29. France Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 30. France Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 31. France Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 32. France Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 33. Italy Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 34. Italy Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 35. Italy Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 36. Italy Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 37. Spain Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 38. Spain Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 39. Spain Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 40. Spain Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 41. Rest of Europe Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 42. Rest of Europe Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 43. Rest of Europe Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 44. Rest of Europe Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 45. Asia Pacific Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 46. Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 47. Asia Pacific Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 48. Asia Pacific Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 49. China Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 50. China Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 51. China Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 52. China Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 53. Japan Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 54. Japan Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 55. Japan Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 56. Japan Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 57. India Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 58. India Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 59. India Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 60. India Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 61. Australia Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 62. Australia Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 63. Australia Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 64. Australia Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 65. South Korea Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 66. South Korea Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 67. South Korea Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 68. South Korea Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 69. Rest of Asia Pacific Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 70. Rest of Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 71. Rest of Asia Pacific Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 72. Rest of Asia Pacific Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 73. Middle East & Africa Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 74. Middle East & Africa Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 75. Middle East & Africa Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 76. Middle East & Africa Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 77. South Africa Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 78. South Africa Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 79. South Africa Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 80. South Africa Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 81. Saudi Arabia Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 82. Saudi Arabia Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 83. Saudi Arabia Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 84. Saudi Arabia Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 85. UAE Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 86. UAE Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 87. UAE Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 88. UAE Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 89. Rest of Middle East & Africa Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 90. Rest of Middle East & Africa Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 91. Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 92. Rest of Middle East & Africa Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 93. South & Central America Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 94. South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 95. South & Central America Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 96. South & Central America Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 97. Brazil Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 98. Brazil Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 99. Brazil Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 100. Brazil Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 101. Argentina Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 102. Argentina Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 103. Argentina Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 104. Argentina Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 105. Rest of South & Central America Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)
Table 106. Rest of South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of South & Central America Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of South & Central America Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 109. Recent Growth Strategies in the Lung Cancer Screening Market
Table 110. Glossary of Terms
LIST OF FIGURES
Figure 1. Lung Cancer Screening Market Segmentation
Figure 2. Lung Cancer Screening Market, by Region
Figure 3. Global Lung Cancer Screening Market Overview
Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Lung Cancer Screening Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Lung Cancer Screening Market, by Geography (US$ Million)
Figure 7. Global Lung Cancer Screening Market – Leading Country Markets (US$ Million)
Figure 8. North America: PEST Analysis
Figure 9. Europe: PEST Analysis
Figure 10. Asia Pacific: PEST Analysis
Figure 11. South & Central America: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. Experts’ Opinion
Figure 14. Lung Cancer Screening Market Impact Analysis of Driver and Restraints
Figure 15. Global Lung Cancer Screening Market – Revenue Forecast and Analysis – 2020-2030
Figure 16. Global Lung Cancer Screening Market, by Geography – Forecast and Analysis (2022 & 2030)
Figure 17. Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
Figure 18. Non–Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Small Cell Lung Cancer: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
Figure 21. Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 22. Chest X-ray: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 23. Liquid Biopsy: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 25. Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
Figure 26. & Older: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
Figure 29. Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. North America: Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Million)
Figure 33. North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. North America: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
Figure 35. US: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Canada: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Mexico: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. Europe: Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Million)
Figure 39. Europe Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 40. Europe: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
Figure 41. Germany: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. UK: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. France: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 44. Italy: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 45. Spain: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 46. Rest of Europe: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 47. Asia Pacific: Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Million)
Figure 48. Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 49. Asia Pacific: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
Figure 50. China: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 51. Japan: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. India: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 53. Australia: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 54. South Korea: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 55. Rest of Asia Pacific: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 56. Middle East & Africa: Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Million)
Figure 57. Middle East & Africa Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 58. Middle East & Africa: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
Figure 59. South Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 60. Saudi Arabia: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 61. UAE: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 62. Rest of Middle East & Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 63. South & Central America: Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Million)
Figure 64. South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 65. South & Central America: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
Figure 66. Brazil: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 67. Argentina: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 68. Rest of South & Central America: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 69. Pre and Post Impact of COVID-19 Pandemic on Markets
The List of Companies - Lung Cancer Screening Market
- Intelerad Medical Systems Incorporated
- Nuance Communications Inc
- GE HealthCare Technologies Inc
- Medtronic Plc
- Canon Medical Systems Corp
- Koninklijke Philips NV
- Siemens AG
- CVS Health
- bioAffinity Technologies, Inc.
- LungLife AI, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For